LncRNA SNHG14 Regulated by ZNF460 Promotes Gastric Cancer Progression and Metastasis by Targeting the miR ‐206/ FNDC3A Axis
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70652 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Bin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Lanzhou University, Lanzhou, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, MicroRNAs, RNA, Long Noncoding, Transcription Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The 2022 Master/Doctor/Postdoctoral program of NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, National Natural Science Foundation of China, GanSu Joint Scientific Research Fund Major Project.
Abstract (Originalsprache)
The current study investigated the functional role of long non‐coding RNA SNHG14 (lncRNA SNHG14) in gastric cancer (GC) progression and its underlying mechanisms. Compared with para‐carcinoma tissues, SNHG14 was upregulated in GC tissues, correlating with a poor prognosis in GC patients. SNHG14 knockdown significantly weakened the proliferation, migration and invasion capabilities of GC cell lines while enhancing the apoptosis ability of GC cells. Simultaneously, SNHG14 overexpression reversed these effects. RNA fluorescence in situ hybridization (FISH) and nucleocytoplasmic separation assays revealed that SNHG14 was primarily located in the cytoplasm of GC cells. Combined sequencing of the miRNAome and transcriptome depicted that miR‐206 could be a potential target for SNHG14. Mechanistically, assays such as luciferase reporter, RNA immunoprecipitation (RIP) and RNA pulldown established that lncRNA SNHG14 acted as a sponge for miR‐206. This prevented the degradation of its target gene, FNDC3A, playing a tumour‐suppressive role in GC. In addition, FNDC3A directly interacted with the SNHG14 promoter and induced transcription, thus facilitating GC progression. Therefore, our research findings suggested a novel pathway to promote GC progression through the FNDC3A/lncRNA SNHG14/miR‐206/FNDC3A axis. Moreover, the findings indicated that SNHG14 could become a potential biomarker and therapeutic target for GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
- NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor, Gansu Provincial Hospital, Lanzhou, China.
- Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province, Gansu Provincial Hospital, Lanzhou, China.
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
- Phase I Clinical & Research Ward, Gansu Provincial Hospital, Lanzhou, China.
ORCID-Profile: Hui Cai
Förderung
- The 2022 Master/Doctor/Postdoctoral program of NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor
- National Natural Science Foundation of China
- GanSu Joint Scientific Research Fund Major Project
- 2024 Gansu Provincial Hospital Special Fund of NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumor
Zitieren
APA
Liu, B., Lu, T., Zhang, G., Dong, X., Yu, M., & Cai, H. (2025). LncRNA SNHG14 Regulated by ZNF460 Promotes Gastric Cancer Progression and Metastasis by Targeting the miR ‐206/ FNDC3A Axis. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70652
Vancouver
Liu B, Lu T, Zhang G, Dong X, Yu M, Cai H. LncRNA SNHG14 Regulated by ZNF460 Promotes Gastric Cancer Progression and Metastasis by Targeting the miR ‐206/ FNDC3A Axis. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70652
BibTeX
@article{Liu2025,
author = {Liu, Bin and Lu, Tingting and Zhang, Guangming and Dong, Xiaohua and Yu, Miao and Cai, Hui},
title = {LncRNA SNHG14 Regulated by ZNF460 Promotes Gastric Cancer Progression and Metastasis by Targeting the miR ‐206/ FNDC3A Axis},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70652}
}
EUVIMED